Group One Trading
VTGN icon

Group One Trading’s VistaGen Therapeutics VTGN Stock Holding History

Group One Trading’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$64.3K Sell
208,748
-95,637
-31% -$24.2K ﹤0.01% 5063
2026
Q2 		$68.8K Buy
304,385
+284,510
+1,431% +$172K ﹤0.01% 5140
2026
Q1 		$11.4K Sell
19,875
-86,262
-81% -$52.4K ﹤0.01% 6307
2025
Q4 		$70.3K Buy
106,137
+77,209
+267% +$279K ﹤0.01% 5302
2025
Q3 		$103K Buy
28,928
+21,786
+305% +$65.1K ﹤0.01% 5324
2025
Q2 		$14.3K Buy
7,142
+1,573
+28% +$3.57K ﹤0.01% 6494
2025
Q1 		$13.9K Sell
5,569
-92,158
-94% -$261K ﹤0.01% 6051
2024
Q4 		$288K Buy
+97,727
New +$275K ﹤0.01% 3622
2023
Q4 		– Sell
-75,305
Closed -$285K – 8268
2023
Q3 		$395K Buy
75,305
+72,913
+3,048% +$324K ﹤0.01% 3150
2023
Q2 		$4.47K Sell
2,392
-899
-27% -$3.15K ﹤0.01% 6767
2023
Q1 		$12.3K Sell
3,291
-1,194
-27% -$6.26K ﹤0.01% 5821
2022
Q4 		$13.9K Sell
4,485
-9,729
-68% -$36.6K ﹤0.01% 5845
2022
Q3 		$65K Buy
14,214
+9,686
+214% +$96K ﹤0.01% 5186
2022
Q2 		$120K Buy
+4,528
New +$160K ﹤0.01% 4810

Other funds holding VTGN

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Group One Trading's VTGN Position: Q3 2026 in Review

Group One Trading reduced its VistaGen Therapeutics (VTGN) stake by 31% in Q3 2026, selling an estimated $24.2K and leaving 208,748 shares worth $64.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5063.

Group One Trading first reported a position in VTGN in Q2 2022 and has held it in 14 quarters since. The position peaked at $395K in Q3 2023. 22 funds tracked by Wall St. Rank hold VTGN as of Q3 2026.

  • Group One Trading held 208,748 shares of VistaGen Therapeutics worth $64.3K as of Q3 2026.
  • Group One Trading sold 95,637 VistaGen Therapeutics shares in Q3 2026, an estimated $24.2K.
  • VistaGen Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5063 holding.
  • Group One Trading first reported a position in VistaGen Therapeutics in Q2 2022 and has held it in 14 quarters since.
  • Group One Trading's VistaGen Therapeutics position peaked at $395K in Q3 2023.
  • 22 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.